Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1995
Cloning of the rat ecotropic retroviral receptor and studies of its expression in intestinal tissues
M Puppi, S J Henning
International Journal of Radiation Biology
|
September 26, 2001
Time-dose relationships in radiation-enhanced integration
C W Stevens, M Puppi, G J Cerniglia
Inflammatory Bowel Diseases
|
November 28, 2008
Alterations in myeloid dendritic cell innate immune responses in the Galphai2-deficient mouse model of colitis
J A Peña, L Thompson-Snipes, P R Calkins, et al.
The Journal of Biological Chemistry
|
November 22, 1996
Molecular sites of regulation of expression of the rat cationic amino acid transporter gene
K S Aulak, J Liu, J Wu, et al.
Leukemia
|
November 23, 2016
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway
Y Shen, C S Park, K Suppipat, et al.
Journal of Cancer Research and Clinical Oncology
|
October 9, 2025
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
M Talarico, S Barbato, V Maisnar, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
May 16, 2025
Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing
M Puppi, I Sacchetti, K Mancuso, et al.
Journal of Bone Oncology
|
March 24, 2025
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
M Talarico, S Barbato, A Cattabriga, et al.
European Journal of Haematology
|
March 11, 2026
Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic Landscape
K Mancuso, S Masci, M Talarico, et al.
Clinical and Experimental Medicine
|
November 25, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide
I Rizzello, I Sacchetti, S Barbato, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1995
Cloning of the rat ecotropic retroviral receptor and studies of its expression in intestinal tissues
M Puppi, S J Henning
International Journal of Radiation Biology
|
September 26, 2001
Time-dose relationships in radiation-enhanced integration
C W Stevens, M Puppi, G J Cerniglia
Inflammatory Bowel Diseases
|
November 28, 2008
Alterations in myeloid dendritic cell innate immune responses in the Galphai2-deficient mouse model of colitis
J A Peña, L Thompson-Snipes, P R Calkins, et al.
The Journal of Biological Chemistry
|
November 22, 1996
Molecular sites of regulation of expression of the rat cationic amino acid transporter gene
K S Aulak, J Liu, J Wu, et al.
Leukemia
|
November 23, 2016
Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway
Y Shen, C S Park, K Suppipat, et al.
Journal of Cancer Research and Clinical Oncology
|
October 9, 2025
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
M Talarico, S Barbato, V Maisnar, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
May 16, 2025
Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing
M Puppi, I Sacchetti, K Mancuso, et al.
Journal of Bone Oncology
|
March 24, 2025
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
M Talarico, S Barbato, A Cattabriga, et al.
European Journal of Haematology
|
March 11, 2026
Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic Landscape
K Mancuso, S Masci, M Talarico, et al.
Clinical and Experimental Medicine
|
November 25, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide
I Rizzello, I Sacchetti, S Barbato, et al.
Page
of 2